Minutia
Curing and monitoring type 1 diabetes
Minutia is a company in therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2021.
Profile
A functional cure for Type I Diabetes which does not require systemic immunosuppressants or an invasive transplant procedure, plus built-in safety monitoring and kill switch functionalities.
The company sits in the therapeutics segment, where it competes on its core product or service.
Europe, Middle East, and Africa (EMEA) is where the company is located.
It is recorded at the Seed stage.
Recorded headcount: 11-50 employees.
Public records show total funding of about $6.9M.
| Sector | Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Country | United States |
| Founded | 2021 |
| Employees | 11-50 |
| Stage | seed |
| Total funding | $6,900,000 |
Website: www.minutia.co
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account